Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers

E. Akhter, R. W. Burlingame, A. L. Seaman, L. Magder, Michelle Petri

Research output: Contribution to journalArticle

Abstract

Objective. Autoantibodies are important in the diagnosis and classification of systemic lupus erythematosus (SLE), but whether they correlate with changes in disease activity within individual patients is controversial. We assessed the association between changes in SLE global and renal activity and changes in several autoantibodies and cell adhesion molecules in patients with SLE. Methods. Stored sera collected at two or three clinic visits from each of 49 SLE patients (91% female, 59% African-American, 31% Caucasian, 10% other ethnicity, 38% under 30 years, 41% between 30-44 years, and 21% 45-63 years) were analyzed. The visits were chosen to include one visit with proteinuria, and one or two without, for each patient. Global disease activity was measured by the Physician's Global Assessment (PGA), SELENA-SLEDAI (SLE Disease Activity Index modified to exclude anti-dsDNA and complement) and renal activity assessed by urine protein (by urine dipstick) and Renal Activity Score. Sera were assayed for anti-C1q, anti-chromatin, anti-dsDNA, anti-ribosomal P, monocyte chemotactic protein-1 (MCP-1), vascular cell adhesion molecule (VCAM) intercellular adhesion molecule (ICAM) and complement. The associations between changes in disease activity and changes in biomarker levels were assessed. Results. In terms of global disease activity, anti-C1q had the highest association with the PGA (p = 0.09) and was strongly associated with modified SELENA-SLEDAI (p = 0.009). In terms of renal activity, anti-C1q had the highest association with proteinuria (p = 0.079), and was strongly associated with Renal Activity Score (p = 0.006). Conclusion. Anti-C1q performed the best of the potential biomarkers, being significantly associated with the modified SELENA-SLEDAI and with the Renal Activity Score. This study indicates the potential superior utility of anti-C1q over anti-dsDNA and other measures to track renal activity.

Original languageEnglish (US)
Pages (from-to)1267-1274
Number of pages8
JournalLupus
Volume20
Issue number12
DOIs
StatePublished - Oct 2011

Fingerprint

Lupus Nephritis
Anti-Idiotypic Antibodies
Biomarkers
Systemic Lupus Erythematosus
Kidney
Cell Adhesion Molecules
Proteinuria
Autoantibodies
Urine
Physicians
Vascular Cell Adhesion Molecule-1
Chemokine CCL2
Ambulatory Care
Serum
African Americans
Chromatin

Keywords

  • anti-C1q
  • lupus nephritis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers. / Akhter, E.; Burlingame, R. W.; Seaman, A. L.; Magder, L.; Petri, Michelle.

In: Lupus, Vol. 20, No. 12, 10.2011, p. 1267-1274.

Research output: Contribution to journalArticle

Akhter, E. ; Burlingame, R. W. ; Seaman, A. L. ; Magder, L. ; Petri, Michelle. / Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers. In: Lupus. 2011 ; Vol. 20, No. 12. pp. 1267-1274.
@article{c3ef6b34a2be4851b531f8a60eadc39c,
title = "Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers",
abstract = "Objective. Autoantibodies are important in the diagnosis and classification of systemic lupus erythematosus (SLE), but whether they correlate with changes in disease activity within individual patients is controversial. We assessed the association between changes in SLE global and renal activity and changes in several autoantibodies and cell adhesion molecules in patients with SLE. Methods. Stored sera collected at two or three clinic visits from each of 49 SLE patients (91{\%} female, 59{\%} African-American, 31{\%} Caucasian, 10{\%} other ethnicity, 38{\%} under 30 years, 41{\%} between 30-44 years, and 21{\%} 45-63 years) were analyzed. The visits were chosen to include one visit with proteinuria, and one or two without, for each patient. Global disease activity was measured by the Physician's Global Assessment (PGA), SELENA-SLEDAI (SLE Disease Activity Index modified to exclude anti-dsDNA and complement) and renal activity assessed by urine protein (by urine dipstick) and Renal Activity Score. Sera were assayed for anti-C1q, anti-chromatin, anti-dsDNA, anti-ribosomal P, monocyte chemotactic protein-1 (MCP-1), vascular cell adhesion molecule (VCAM) intercellular adhesion molecule (ICAM) and complement. The associations between changes in disease activity and changes in biomarker levels were assessed. Results. In terms of global disease activity, anti-C1q had the highest association with the PGA (p = 0.09) and was strongly associated with modified SELENA-SLEDAI (p = 0.009). In terms of renal activity, anti-C1q had the highest association with proteinuria (p = 0.079), and was strongly associated with Renal Activity Score (p = 0.006). Conclusion. Anti-C1q performed the best of the potential biomarkers, being significantly associated with the modified SELENA-SLEDAI and with the Renal Activity Score. This study indicates the potential superior utility of anti-C1q over anti-dsDNA and other measures to track renal activity.",
keywords = "anti-C1q, lupus nephritis",
author = "E. Akhter and Burlingame, {R. W.} and Seaman, {A. L.} and L. Magder and Michelle Petri",
year = "2011",
month = "10",
doi = "10.1177/0961203311411597",
language = "English (US)",
volume = "20",
pages = "1267--1274",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "12",

}

TY - JOUR

T1 - Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers

AU - Akhter, E.

AU - Burlingame, R. W.

AU - Seaman, A. L.

AU - Magder, L.

AU - Petri, Michelle

PY - 2011/10

Y1 - 2011/10

N2 - Objective. Autoantibodies are important in the diagnosis and classification of systemic lupus erythematosus (SLE), but whether they correlate with changes in disease activity within individual patients is controversial. We assessed the association between changes in SLE global and renal activity and changes in several autoantibodies and cell adhesion molecules in patients with SLE. Methods. Stored sera collected at two or three clinic visits from each of 49 SLE patients (91% female, 59% African-American, 31% Caucasian, 10% other ethnicity, 38% under 30 years, 41% between 30-44 years, and 21% 45-63 years) were analyzed. The visits were chosen to include one visit with proteinuria, and one or two without, for each patient. Global disease activity was measured by the Physician's Global Assessment (PGA), SELENA-SLEDAI (SLE Disease Activity Index modified to exclude anti-dsDNA and complement) and renal activity assessed by urine protein (by urine dipstick) and Renal Activity Score. Sera were assayed for anti-C1q, anti-chromatin, anti-dsDNA, anti-ribosomal P, monocyte chemotactic protein-1 (MCP-1), vascular cell adhesion molecule (VCAM) intercellular adhesion molecule (ICAM) and complement. The associations between changes in disease activity and changes in biomarker levels were assessed. Results. In terms of global disease activity, anti-C1q had the highest association with the PGA (p = 0.09) and was strongly associated with modified SELENA-SLEDAI (p = 0.009). In terms of renal activity, anti-C1q had the highest association with proteinuria (p = 0.079), and was strongly associated with Renal Activity Score (p = 0.006). Conclusion. Anti-C1q performed the best of the potential biomarkers, being significantly associated with the modified SELENA-SLEDAI and with the Renal Activity Score. This study indicates the potential superior utility of anti-C1q over anti-dsDNA and other measures to track renal activity.

AB - Objective. Autoantibodies are important in the diagnosis and classification of systemic lupus erythematosus (SLE), but whether they correlate with changes in disease activity within individual patients is controversial. We assessed the association between changes in SLE global and renal activity and changes in several autoantibodies and cell adhesion molecules in patients with SLE. Methods. Stored sera collected at two or three clinic visits from each of 49 SLE patients (91% female, 59% African-American, 31% Caucasian, 10% other ethnicity, 38% under 30 years, 41% between 30-44 years, and 21% 45-63 years) were analyzed. The visits were chosen to include one visit with proteinuria, and one or two without, for each patient. Global disease activity was measured by the Physician's Global Assessment (PGA), SELENA-SLEDAI (SLE Disease Activity Index modified to exclude anti-dsDNA and complement) and renal activity assessed by urine protein (by urine dipstick) and Renal Activity Score. Sera were assayed for anti-C1q, anti-chromatin, anti-dsDNA, anti-ribosomal P, monocyte chemotactic protein-1 (MCP-1), vascular cell adhesion molecule (VCAM) intercellular adhesion molecule (ICAM) and complement. The associations between changes in disease activity and changes in biomarker levels were assessed. Results. In terms of global disease activity, anti-C1q had the highest association with the PGA (p = 0.09) and was strongly associated with modified SELENA-SLEDAI (p = 0.009). In terms of renal activity, anti-C1q had the highest association with proteinuria (p = 0.079), and was strongly associated with Renal Activity Score (p = 0.006). Conclusion. Anti-C1q performed the best of the potential biomarkers, being significantly associated with the modified SELENA-SLEDAI and with the Renal Activity Score. This study indicates the potential superior utility of anti-C1q over anti-dsDNA and other measures to track renal activity.

KW - anti-C1q

KW - lupus nephritis

UR - http://www.scopus.com/inward/record.url?scp=80053637222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053637222&partnerID=8YFLogxK

U2 - 10.1177/0961203311411597

DO - 10.1177/0961203311411597

M3 - Article

C2 - 21813587

AN - SCOPUS:80053637222

VL - 20

SP - 1267

EP - 1274

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 12

ER -